About laurabbook@gmail.com

This author has not yet filled in any details.
So far laurabbook@gmail.com has created 33 blog entries.
25 September 2019

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity

2019-09-25T15:17:16-07:00

*August 2019*  Science Immunology Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line therapy for rapidly killing

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity2019-09-25T15:17:16-07:00